| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 27th January 2020 | Linda F Powers | 220,000 | Open or private sale | $4.60 | $1,012,000.00 |
| 11th September 2019 | Mark William Lowdell | 2,918 | Open or private purchase | $6.23 | $18,178.56 |
| 21st August 2019 | Scott Juda | 2,500 | Open or private purchase | $6.00 | $15,000.00 |
| 20th August 2019 | Raymond Joseph Tesi | 100 | Open or private purchase | $5.96 | $596.00 |
| 20th August 2019 | Raymond Joseph Tesi | 100 | Open or private purchase | $5.96 | $596.00 |
| 20th August 2019 | Raymond Joseph Tesi | 100 | Open or private purchase | $5.96 | $596.00 |
| 20th August 2019 | Raymond Joseph Tesi | 100 | Open or private purchase | $5.96 | $596.00 |
| 20th August 2019 | Raymond Joseph Tesi | 100 | Open or private purchase | $5.96 | $596.00 |
| 20th August 2019 | Raymond Joseph Tesi | 100 | Open or private purchase | $5.96 | $596.00 |
| 20th August 2019 | Scott Juda | 2,500 | Open or private purchase | $6.00 | $15,000.00 |
I Nmune Bio
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Inmune Bio, Inc. develops immunotherapies that reprogram a patient's innate immune system to fight cancer. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.
Ticker: INMB
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1711754
Employees: 4
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
